Scarica l'app Stockscreener
140.12
5.03%
-7.5388
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMDX Giù?
Forum
Previsione
Transmedics Group Inc Borsa (TMDX) Ultime notizie
Anil Ranganath Sells 864 Shares of TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
Insider Selling: TransMedics Group (NASDAQ:TMDX) CFO Sells 375 Shares of Stock - MarketBeat
TransMedics group CFO Hernandez sells shares worth $1.12 million - Investing.com
Nicholas Corcoran Sells 2,966 Shares of TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
TransMedics Group (NASDAQ:TMDX) CFO Sells $1,065,211.56 in Stock - MarketBeat
TransMedics group CFO Hernandez sells shares worth $1.12 million By Investing.com - Investing.com UK
The medtech firm’s latest quarter showed organ demand – and profits – continuing to rise. - Finimize
TransMedics Group, Inc. $TMDX Shares Acquired by DNB Asset Management AS - MarketBeat
Why TransMedics Group (TMDX) Is Up 9.2% After Strong 2025 Results And 2026 Outlook - simplywall.st
TransMedics Group, Inc. (TMDX) Stock Analysis: Strong Growth with a 54.24% Return on Equity - DirectorsTalk Interviews
TransMedics Group, Inc. $TMDX Shares Acquired by Citigroup Inc. - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect - ACCESS Newswire
TD Cowen Health Care Conference - marketscreener.com
Got $5,000? TransMedics Could Be a High‑Tech Organ Transplant Moonshot - Yahoo Finance
TransMedics Stock Soars After Beating Revenue Expectations and Raising Guidance - timothysykes.com
Wall Street Zen Downgrades TransMedics Group (NASDAQ:TMDX) to Hold - MarketBeat
TransMedics Shares Surge Amid Strong Q4 Financial Performance - StocksToTrade
TransMedics’ Shares Surge on Strong Q4 Results and Price Target Raises - StocksToTrade
TransMedics Stock Surges as Analysts Raise Price Targets Amid Strong Earnings - timothysykes.com
TransMedics Stock Surges After Outstanding Q4 Earnings and Strategic Expansion Plans - StocksToTrade
TransMedics Group (NASDAQ:TMDX) Shares Up 5.9%What's Next? - MarketBeat
Vanguard Group Inc. Buys 9,650 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics provides information on impact of release of valuation allowance on deferred tax assets on previously reported quarterly results - marketscreener.com
TransMedics clarifies Q4 tax benefit impact on earnings - Investing.com
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results - PR Newswire
Analysts’ Top Healthcare Picks: Vaxcyte (PCVX), TransMedics Group (TMDX) - The Globe and Mail
TransMedics Group, Inc. (TMDX): A bull case theory - MSN
Is It Too Late To Consider TransMedics Group (TMDX) After Its 79% One-Year Surge? - Yahoo Finance
TransMedics Group, Inc. (NASDAQ:TMDX) Q4 2025 Earnings Call Transcript - Insider Monkey
TransMedics Group Stock Plunges 4.3% as $350M Surge Propels It to 390th Most Traded Amid Mystery - Bitget
JP Morgan Maintains Neutral Rating for TMDX with Raised Price Ta - GuruFocus
Needham raises TransMedics stock price target to $174 on beat By Investing.com - Investing.com Canada
Oppenheimer Raises Price Target for TransMedics Group (TMDX) to - GuruFocus
JPMorgan Chase & Co. Issues Positive Forecast for TransMedics Group (NASDAQ:TMDX) Stock Price - MarketBeat
TransMedics Group (NASDAQ:TMDX) Stock Price Expected to Rise, Oppenheimer Analyst Says - MarketBeat
TMDX Shares Climb After Q4 Earnings and Revenue Surpass Expectations - Bitget
TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates - Finviz
TransMedics Group, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
TMDX Analyst Rating Update: Piper Sandler Raises Price Target | - GuruFocus
Piper Sandler Forecasts Strong Price Appreciation for TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
Evercore ISI Group Raises Price Target for TransMedics Group (TM - GuruFocus
Oppenheimer Adjusts Price Target on TransMedics to $175 From $150, Maintains Outperform Rating - marketscreener.com
Needham Raises Price Target on TransMedics Group to $174 From $166, Keeps Buy Rating - marketscreener.com
TransMedics revenue up 32% to USD 160.8M in Q4 2025 - Medical Buyer
TransMedics Group (NASDAQ:TMDX) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat
Needham raises TransMedics stock price target to $174 on beat - Investing.com
A Glimpse Into The Expert Outlook On TransMedics Group Through 4 Analysts - Benzinga
TMDX: Needham Raises Price Target to $174, Maintains Buy Rating - GuruFocus
TransMedics (TMDX) stock jumps 7% premarket after earnings, 2026 revenue outlook - TechStock²
TransMedics Group, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:TMDX) 2026-02-25 - Seeking Alpha
TransMedics Group (TMDX) Reports Strong Q4 2025 Growth - GuruFocus
TransMedics Reports Strong Q4 2025 Earnings with Significant Growth - Intellectia AI
TransMedics Group Inc (TMDX): A Strategic SWOT Insight - GuruFocus
TransMedics Group Q4 Earnings Call Highlights - Yahoo Finance
TransMedics Group Inc (TMDX) Q4 2025 Earnings Call Highlights: S - GuruFocus
TransMedics Group Q4 2025 Earnings Call Transcript - MarketBeat
TransMedics (TMDX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
TransMedics (TMDX) Surpasses Q4 Revenue Estimates and Eyes Future Growth - GuruFocus
TransMedics (TMDX) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
TMDX Projects Strong Revenue Growth for FY26 - GuruFocus
Transmedics Group Inc reports results for the quarter ended December 31Earnings Summary - TradingView
TransMedics (TMDX) Reports Strong Q4 Earnings, Surpasses Expecta - GuruFocus
TransMedics Group Q4 Net Income, Revenue Rise; Shares Gain After Hours - marketscreener.com
TransMedics surges on earnings beat, solid guidance By Investing.com - Investing.com UK
TransMedics surges on earnings beat, solid guidance - Investing.com
TransMedics: Fourth Quarter Financial Highlights - Bitget
TransMedics: Q4 Earnings Snapshot - marketscreener.com
2.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):